Statistics for InnoCan Pharma Corp (id:468 INNO)
Valuation metrics
Market cap
53.08M
Enterprise value
78.99M
Trailing P/E (ttm)
-12.35
Forward P/E
PEG ratio
Price/Sales (ttm)
2.18
Price/Book (mrq)
12.33
Enterprise Value/Revenue
2.25
Enterprise Value/EBITDA
-20.04
Overview
Shares outstanding
286.94M
Float
216.82M
Shares short
5.06K
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
27.32K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
3.00
52-Week change
-35.71%
Beta
2.96
50-Day moving average
3.00
200-Day moving average
3.00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-17.80%
Operating margin
6.16%
Operational effectiveness
Return on assets
-23.77%
Return on equity
-56.52%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-3,941,828.00
Net income to common (ttm)
-6,236,797.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
7.46M
Total cash per share (mrq)
5.00
Total debt (mrq)
5.75K
Total Debt/Equity (mrq)
5.00
Current ratio (mrq)
321.80%
Book value per share (mrq)
5.00
Cash flow
Cash flow statement
-3,019,242.00
Levered free cash flow (LFCF)
1.87M